Actavis 10-Q2013 Q1 Quarterly report

Filed: 7 May 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: abandonment, acid, acyclovir, andUnited, Assoc, attributable, award, begun, Building, businesswithina, confirmed, Cordran, corrective, Council, cream, distributor, Eighteen, excellence, exempted, exemption, feasibility, Ferring, flurandrenolide, France, GCSI, GlaxoSmithKline, GSK, Hotel, IA, improve, infertility, inNew, Kadian, Kingdom, legacy, Loestrin, Lysteda, matched, MEAAP, Meijer, mg, Mid, nonprofit, ointment, Opana, optimization, Overview, oxymorphone, Pacific, paroxetine, Pennsylvania, physician, pipeline, point, prospectively, Pub, purportedly, rationalization, reclassified, reconsideration, refiled, renamed, retention, Russia, SA, shipping, solid, strategic, strength, structure, symbol, Tape, telemarketing, tranexamic, Turkey, UK, ultimately, USPTO, Uteron, Valeant, Welfare, withdrew, Zovirax

Removed: ABEE, acquire, Ada, Allen, ALMC, Amgen, Anchorage, Anonyme, antibody, appealing, approximate, Arcolab, Argon, Asian, assume, Attorney, Australasia, Australian, Biovail, Board, branch, Brazil, bridge, capability, Chao, Chemical, choose, collaboration, commercialize, commercializing, construction, Copiague, declared, Delaware, dependent, Deutsche, develop, dismissing, dividend, Division, Drew, DS, Edmondson, effectively, ehf, Eleventh, ella, enhanced, Erie, esomeprazole, European, execution, exert, existence, expertise, expire, extended, ferric, field, fine, fix, follicle, formal, fourth, FraternalOrder, gave, Germany, gluconate, Greek, Groveport, grow, hand, hf, highly, history, Holding, Hong, HSR, Iceland, incorporated, indemnity, India, Industrial, INFeD, influence, initially, internationally, investee, Kong, label, Landsbanki, lifecycle, liquidation, Luxembourg, Lynch, Malaysia, Mandatorily, mistrial, multinational, Nitrogen, Ohio, Oklahoma, Olive, oncology, opportunity, ordered, Oswego, pay, perform, performing, Pharmahealth, platform, Pottawatomie, preferred, premium, President, principle, profitability, recombinant, recording, redeemable, reflecting, relevant, relocating, Republic, require, responsibility, retried, rFSH, Schenectady, shutdown, Singapore, skin, Societe, Specifar, stimulating, sublimit, Territory, test, Thailand, theFraternal, thequi, theStephen, unable, unamortized, USPD, Vendor, Vietnam, Virgin, volume, vote, voting, worldwide

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Actavis similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification of Chief Financial Officer Pursuant to 18 U.S.C. of Section 1350, as Adopted by Section 906 of the

Sarbanes-Oxley Act of 2002

The undersigned officer of Actavis, Inc. (the “Company”), hereby certifies, to such officer’s knowledge, that:

(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 7, 2013



By:		/S/ R. TODD JOYCE
		R. Todd Joyce
		Chief Financial Officer – Global
		(Principal Financial and Accounting Officer)

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.